Role of manganese in the pathogenesis of portal-systemic encephalopathy

Metabolic Brain Disease

Volumn 13, Issue 4, 1998, Pages 311-317

  Pomier Layrargues, G ^a,c   Rose, C ^a   Spahr, L ^a   Zayed, J ^b   Normandin, L ^b   Butterworth, R F ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Extrapyramidal disorders; Globus pallidus; Magnetic Resonance Imaging; Manganese; Portacaval shunt; Portal systemic encephalopathy

Indexed keywords

MANGANESE;

BIOACCUMULATION; CONFERENCE PAPER; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; METAL METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY;

BRAIN; CHRONIC DISEASE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; MANGANESE; NERVOUS SYSTEM;

EID: 6544243990     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020636809063     Document Type: Conference Paper

References (35)

1. Aschner, M. and Aschner, J.L. (1991). Manganese neurotoxicity: cellular effects and blood-brain barrier transport. Neurosci. Biobehav. Rev. 15:333-340.
2. Bergeron, M., Reader, T.A., Pomier-Layrargues, G. and Butterworth R.F. (1989). Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurochem. Res. 14:853-859.
3. Bird, E.D., Anton, A.H. and Bullock, B. (1984). The effect of manganese inhalation on basal ganglia dopamine concentrations in rhesus monkeys. Neuru. Toxicol. 5:59-66.
4. Butterworth, R.F., Giguère, J.F., Michaud, J., Lavoie, J. and Pomier-Layrargues, G. (1987). Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochem. Pathol. 6:1-12.
5. Devenyi, A.G., Barron, T.F. and Mamourian, A.C. (1994). Dystonia, hyperintense basal ganglia and high whole blood manganese levels in Alagille's syndrome. Gastroenterology 106:1068-1071.
6. Drapeau, P. and Nachshev, D.A. (1984). Manganese fluxes and manganese-dependent neurotransmitter release in presynaptic nerve endings isolated from rat brains. J. Physiol. 348:493-510.
7. Hauser, R.A., Zesiewicz, T.A., Martinez, C., Rosemurgy, A.S. and Olanow, C.W. (1996). Blood manganese correlates with brain magnetic resonance imaging changes in patients with liver disease. Can. J. Neurol. Sci. 23:95-98.
8. Hauser, R.A., Zesiewicz, T.A., Rosemurgy, A.S., Martinez, C. and Olanow, C.W. (1994). Manganese intoxication and chronic liver failure. Ann. Neurol. 36:871-875.
9. Iregren, A. (1994). Using psychological tests for the early detection of neurotoxic effects of low level manganese exposure. Neurotoxicology 15:671-678.
10. Krieger, D., Krieger, S., Jansen, D., Gass, P., Theilmann, L. and Lichtnecker H. (1995). Manganese and chronic hepatic encephalopathy. Lancet 346:270-274.
11. 1 -weighted magnetic resonance images in liver cirrhosis. Gastroenterology 111: 147-155.
12. Krieger, D., Jaub, M., Jansen, O., Stiehl, A., Sauer, P., Geilbler, M. et al. (1997). MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: results of a controlled prospective clinical investigation. J. Hepatol. 27:121-126.
13. Kulisevsky, J., Pujol, C., Balanzo, J., Junque, C., Deus, J., Capdevilla, A., and Villanueva, C. (1992). Pallidal hyperintensity on magnetic resonance imaging in cirrhotic patients: clinical correlations. Hepatology 16:1382-1388.
14. Leung, T.K., Lai, J.C.K. and Lin, L. (1981). The regional distribution of monoamine oxidase activities towards different substrates: effects in rat brain of chronic administration of manganese chloride and of ageing. J. Neurochem. 36:2037-2043.
15. Lista, A., Abarca, J., Ramos, C. and Daniels, A.J. (1986). Rat striatal dopamine and tetrahydrobiopterin content following an intra-striatal injection of manganese chloride. Life Sci. 38:2121-2127.
16. 1-weighted images and elemental concentrations in brain. Neuroradiology 39:546-550.
17. Mergler, D. and Baldwin, M. (1994). Early manifestations of manganese neurotoxicity in humans; an update. Experimental Res. 73:92-100.
18. Mirowitz, J.A. and Westrich, T.S. (1992). Basal ganglial signal intensity alterations: reversal after discontinuation of parenteral manganese administration. Radiology 185:535-536.
19. 1-weighted MR Images in patients receiving parenteral nutrition. Radiology 181:117-120.
20. Nelson, K., Golnick, J., Korn, T. and Angle, C. (1993). Manganese encephalopathy: utility of early magnetic resonance imaging. Br. J. Ind. Med. 50:510-513.
21. 1-weighted magnetic resonance images are frequent in patients with portal vein thrombosis without liver cirrhosis and not suggestive of hepatic encephalopathy. J. Hepatol. 29:443-449.
22. Papavasiliou, P.S., Miller, S.T. and Cotzias, G.G. (1966). Role of liver in regulating distribution and excretion of manganese. Am. J. Physiol. 211:211-216.
23. Pomier-Layrargues, G., Spahr, L. and Butterworth, R.F. (1995). Increased manganese concentrations in pallidum of cirrhotic patients. Lancet 345:735.
24. 1-weighted MRI in cirrhotic patients is associated with severity of liver failure. Neurology 43:65-69.
25. B in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Brain Res. 621:349-352.
26. Rose, C., Butterworth, R.F., Zayed, J., Spahr, L., Huet, P.M., Gareau, L. and Pomier-Layrargues, G. (1997). Manganese deposition in basal ganglia structures results from both portal systemic shunting and impaired hepatobiliary elimination. Hepatology 26(suppl.): 182A.
27. Shinotho, H., Snow, B.J., Hewitt, K.A., Pate, B.D., Doudet, D., Nugent, R., Perl, D.P., Olanow, W. and Calne, D.B. (1995). MRI and PET studies of manganese intoxicated monkeys. Neurology 45:1199-1204.
28. Spahr, L., Butterworth, R.F., Fontaine, S., Bui, L., Therrien, G., Milette, P. et al. (1996). Increased blood manganese in cirrhotic patient: relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms. Hepatology 24:1116-1120.
29. Spahr, L., Vingerhoets, F., Lazeyras, F., Delavelle, J., Du Pasquier, R., Giostra, E. et al. (1998). Relationship between brain MRI/MRS and extrapyramidal symptoms in hepatic encephalopathy. Hepatology 28:457A.
30. Subhash, M. and Padmashree, T.S. (1991). Effect of manganese on biogenic amine metabolism in regions of the rat brain. Food and Chem. Toxicol. 29:579-582.
31. 1-weighted and magnetisation transfer contrast measurements with liver dysfunction and neuropsychiatric status. Metab. Brain Dis. 10:175-188.
32. Versiek, J., Barbier, F., Speecke, A. and Hoste, J. (1974). Manganese, copper and zinc concentrations in serum and packed blood cells during acute hepatitis, chronic hepatitis and posthepatitic cirrhosis. Clin. Chem. 20:1141-1145.
33. Weissenborn, K., Ehrenheim, Ch., Hori, A., Kubicka, S. and Manns, M.P. (1995). Pallidal lesions in patients with liver cirrhosis: clinical and MRI evaluation. Metab. Brain Dis. 10:219-228.
34. Yamada, M., Ohno, S., Okayasu, I., Okeda, R., Hatakeyama, S., Watanabe, H. et al. (1986). Chronic manganese poisoning: a neuropathological study with determination of manganese distribution in the brain. Acta Neuropathol. (Berl). 70:273-278.
35. Yanai, S., Taketsugu, M., Sonoda, K., Gondo, K., Tasaki, K., Jijii T. and Fukushige, J. (1995). Patent ductus venosus associated with a hyperintense globus pallidus imaging and pulmonary hypertension. Eur. J. Pediatr. 154:526-529.